A team of researchers including NASA scientists have retracted a December 2012 article because it plagiarized…a 2000 NASA report.
Here’s the notice for “A Fosmid Cloning Strategy for Detecting the Widest Possible Spectrum of Microbes from the International Space Station Drinking Water System,” published in Genomics & Informatics: Continue reading Paper by NASA scientists retracted for plagiarizing NASA report
The Journal of Chemical Sciences, the journal of the Indian Academy of Sciences, has retracted a 2012 paper by a group of researchers in India and South Korea who stole material (and a lot of it) from a 2009 article for their reactant.
The retraction notice (it’s a pdf) speaks quite well for itself:
Continue reading “Clear case of plagiarism” forces retraction of chemistry paper
What are the chances of successfully duplicating publication in the Journal of Theoretical Probability? Not too high, it seems.
A pair of South Korean authors have gotten a five-year ban from the journal for double-publishing a paper in the math literature.
The article, “Convergence of Weighted Sums for Arrays of Negatively Dependent Random Variables and Its Applications,” was written by Jong-Il Baek and Sung-Tae Park of Wonkwang University in IkSan.
According to the retraction notice: Continue reading Double submission leads to retraction of probability paper — and a publishing ban
The International Journal of Human-Computer Interaction has retracted four papers about virtual reality for reasons that aren’t quite clear.
The common author of the studies is Dong-Hee Shin of Seoul’s Sungkyunkwan University. Here’s the retraction notice, which is signed by journal editors-in-chief Gavriel Salvendy and Julie Jacko: Continue reading Four papers about gaming and virtual worlds become more virtual and less reality as they’re retracted
Experimental & Molecular Medicine has retracted a 2012 paper on stroke by a group of South Korean researchers after learning that one of the figures in the article was unreliable.
The article was titled “Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury,” and it came from a team at Hallym University in Chunchon.
According to the retraction notice: Continue reading Updated: Integrity “uncertain,” journal retracts stroke paper
Cell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned.
The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as Peer1, identified “several examples of image reuse which might be of interest to PubPeer members and readers:” Continue reading Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper
Here at Retraction Watch, we’ve covered retractions for misconduct, journal errors, editorial system hacking and even no particular reason.
And that’s just in the last week.
However, we’ve identified a new reported reason: carelessness. A paper in Molecular and Cellular Biochemistry claimed to show how a tiny RNA causes fat cells to die.
Instead, the paper died.
Turned out that rather than describe previously published data, the authors say they inadvertently included a figure that had already appeared in another paper.
The retraction for “miR-598 induces replicative senescence in human adipose tissue-derived mesenchymal stem cells via silent information regulator 1,” reads, in full: Continue reading RNA paper retracted for “carelessness in including some of the figures”
A bit of intellectual property indiscretion has led to the retraction of a paper by Korean scientists. Although the details are fuzzy, several of the authors are affiliated with a Korean pharma company called SK.
The paper, “A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons,” was published in the The Korean Journal of Physiology & Pharmacology earlier this year.
According to the retraction notice: Continue reading Loose lips sink paper on company’s experimental pain drug
The authors of a clinical study of an herbal medication have retracted after it became clear that one of the study authors had included two figures without the consent of his co-investigators.
The paper was a study of Green Cross Corporation of Korea’s SHINBARO, which was approved last year for the treatment of osteoarthritis by the Korean FDA.
The editors of the Archives of Pharmacal Research, where the research found a home, ran this notice: Continue reading Herbal arthritis remedy study retracted for “copyright issues”
Hyung-In Moon, the South Korean plant compound researcher who made up email addresses so he could do his own peer review, is now up to 35 retractions.
The four new retractions are of the papers in the Journal of Enzyme Inhibition and Medicinal Chemistry that initially led to suspicions when all the reviews came back within 24 hours. Here’s the notice, which includes the same language as Moon’s 24 other retractions of studies published in Informa Healthcare journals: Continue reading Retraction count grows to 35 for scientist who faked emails to do his own peer review